W. Walther et U. Stein, CELL-TYPE-SPECIFIC AND INDUCIBLE PROMOTERS FOR VECTORS IN GENE-THERAPY AS AN APPROACH FOR CELL TARGETING, Journal of molecular medicine, 74(7), 1996, pp. 379-392
Citations number
82
Categorie Soggetti
Medical Laboratory Technology","Genetics & Heredity
Gene therapy is used to correct genetic defects or to deliver new ther
apeutic functions to the target cells. Viral vectors are employed main
ly as a gene delivery system. A great variety of viral expression syst
ems have been developed and assessed for their ability to transfer gen
es into somatic cells. In particular, retroviral and adenoviral mediat
ed gene transfer have been extensively studied and improved. Preclinic
al and clinical studies covering a large range of genetic disorders ar
e currently underway to solve basic issues dealing with gene transfer
efficiencies, regulation of gene expression, and potential risks of th
e use of viral vectors. The majority of clinical gene therapy trials t
hat employ viral vectors perform ex vivo gene transfer into target cel
ls. The main issue in potential clinical application of gene therapy i
s the need for increased gene transfer efficiency and target specifici
ty associated with regulated gene expression at therapeutically releva
nt levels in vivo. Gene regulatory elements, such as promoters and enh
ancers, possess cell type specific activities and can be activated by
certain induction factors (e.g., hormones, growth factors, cytokines,
cytostatics, irradiation, heat shock) via responsive elements. A contr
oled and restricted expression of these genes can be achieved using su
ch regulatory elements as internal promoters to drive the expression o
f therapeutic genes in viral vector constructs. In addition to high le
vel and efficient gene expression, minimizing or excluding inappropria
te gene expression in surrounding nontarget cells is of great importan
ce for numerous gene therapeutic approaches. This contribution furnish
es insight into the field of cell type specific promoter and enhancer
systems which have been used for targeted and inducible expression of
therapeutic genes in certain genetic disorders, viral infections, and
malignancies. We also discuss promoters that represent attractive cand
idates for the construction of viral vectors.